Company Ticker News March 3, 2022Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022 0 0 Share
Company Ticker News March 2, 2022Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022 0 0 Share
Company Ticker News February 9, 2022Codex DNA to Participate in the SVB Leerink 11th Annual Global Healthcare Conference 0 0 Share
Press Release January 10, 2022Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to Further Develop Codex DNA's Novel Enzymatic DNA Synthesis Technology for Pfizer's use in its Research and Development of mRNA-based Vaccines and Biotherapies 0 0 Share
Press Release December 23, 2021Codex DNA Expands Catalog of COVID-19 Tools with Release of Full-Length Synthetic Genome for SARS-CoV-2 Omicron Variant 0 0 Share
Press Release November 29, 2021Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System 0 0 Share
Company Ticker News November 14, 2021Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q3 2021 Results - Earnings Call Transcript 0 0 Share
